Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms.
暂无分享,去创建一个
E. Prystowsky | W. Jackman | D. Zipes | J. Heger | R. Rinkenberger | G. Naccarelli | Warren M. Jackman | G. V. Naccarelli
[1] E. Prystowsky,et al. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. , 1981, The New England journal of medicine.
[2] D. Zipes,et al. Ventricular Tachycardia and Ventricular Fibrillation in a Young Population , 1979, Circulation.
[3] W. Nicholson,et al. Disopyramide-induced ventricular fibrillation. , 1979, The American journal of cardiology.
[4] L. Horowitz,et al. Recurrent Sustained Ventricular Tachycardia 3. Role of the Electrophysiologic Study in Selection of Antiarrhythmic Regimens , 1978, Circulation.
[5] Randolph P. Martin,et al. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity. , 1978, American Journal of Cardiology.
[6] R. Winkle,et al. Electrode-Catheter Arrhythmia Induction in the Selection and Assessment of Antiarrhythmic Drug Therapy for Recurrent Ventricular Tachycardia , 1978, Circulation.
[7] J. Fisher,et al. Cardiac pacing and pacemakers II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias. , 1977, American heart journal.
[8] G. W. Snedecor. STATISTICAL METHODS , 1967 .
[9] J. Cummings,et al. Quinidine Syncope: Paroxysmal Ventricular Fibrillation Occurring during Treatment of Chronic Atrial Arrhythmias , 1964, Circulation.